Since mid-March Bangladesh has faced an escalating measles outbreak, with suspected cases climbing into the tens of thousands in recent weeks, revealing underlying accumulated gaps in this seemingly robust vaccine framework, and emphasizing the need to identify the origin of these vulnerabilities and address them.